Candel Therapeutics Inc (CADL)

Candel Therapeutics Inc. is a pioneering biotechnology company leveraging oncolytic virus technology to develop targeted therapies that precisely attack cancer cells while preserving surrounding healthy tissue. The company aims to enhance anti-tumor immunity through its diverse pipeline, which addresses several difficult-to-treat malignancies. With a strong intellectual property portfolio and strategic alliances with leading research institutions, Candel is poised to drive significant advancements in cancer treatment, ultimately improving patient outcomes and contributing to the evolution of oncology.